Why Wegovy and Mounjaro Doses Work Differently
Understanding Wegovy Doses vs Mounjaro Mechanisms
The fundamental difference between Wegovy doses and Mounjaro lies in their molecular targets and mechanisms of action. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural incretin hormone to reduce appetite and promote satiety after smaller meals. Its 5-dose escalation protocol from 0.25mg to 2.4mg maintenance allows your body to gradually adjust to the medication's effects over 16 weeks.
Mounjaro (tirzepatide) represents a dual-action approach, targeting both GLP-1 and GIP receptors simultaneously. This dual mechanism may provide additional metabolic benefits, with 6 available doses ranging from 2.5mg to 15mg. While both medications require prescription through clinical assessment, understanding these mechanistic differences helps explain why some patients respond better to one approach over the other, making personalised prescriber guidance essential.
Wegovy Doses Pricing Structure vs Mounjaro Costs
EverydayMeds offers transparent pricing for all Wegovy doses, starting with the 0.25mg starter dose at £79.99, progressing through 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99), and reaching the 2.4mg maintenance dose at £209.99. New customers apply code FIRST40 at checkout, while returning customers use DOSE25 to access these prices. Our Getting Started bundles like the Intro Duo (0.25mg & 0.5mg) at £169.99 provide convenience for the initial escalation phases.
Mounjaro pricing follows a different structure due to its distinct dosing regimen and manufacturing costs. Both medications represent significant investments in long-term weight management, but the choice between Wegovy doses and Mounjaro shouldn't be based solely on cost considerations. Your prescriber can evaluate which medication's dosing schedule, mechanism of action, and side effect profile align best with your individual health profile and lifestyle requirements.
Clinical Evidence Behind Wegovy Doses vs Mounjaro
The STEP clinical trial programme demonstrated that patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks in STEP 1, with the 2.4mg maintenance dose showing sustained efficacy. The SELECT cardiovascular outcomes trial further revealed a 20% reduction in major cardiovascular events, highlighting benefits beyond weight management.
Mounjaro's clinical evidence comes from the SURMOUNT trial series, which evaluated tirzepatide's dual GLP-1/GIP mechanism in weight management populations. Both medications have undergone rigorous clinical testing, but direct head-to-head comparisons weren't conducted due to different trial designs and timelines, making it impossible to definitively compare their relative efficacy percentages.
How Wegovy Doses Target Weight Management
Wegovy's semaglutide works by binding to GLP-1 receptors in your brain's appetite control centres, specifically the hypothalamus, to reduce hunger signals and increase feelings of fullness after eating. The graduated dosing schedule allows your body to adapt to these neurological changes gradually, minimising potential gastrointestinal side effects while maximising therapeutic benefits. Each weekly injection maintains steady semaglutide levels in your bloodstream, providing consistent appetite regulation throughout the week. The 5-dose escalation from 0.25mg to 2.4mg ensures you reach the optimal therapeutic level safely, with most patients achieving significant appetite reduction by the 1mg dose. This mechanism works most effectively when combined with portion control and regular physical activity, as the medication enhances your natural ability to feel satisfied with smaller meal sizes.
EverydayMeds Wegovy Doses Ordering Process
Getting started with Wegovy doses through EverydayMeds begins with our 3-minute online clinical assessment, designed to evaluate your suitability for this prescription-only medicine. Our GPhC-registered prescribers (#9012878) review your assessment within 3 working days (or 24 hours with express service), ensuring safe and appropriate prescribing based on MHRA guidelines for weight management. Once approved, your chosen Wegovy dose is dispatched via temperature-controlled next-day delivery, maintaining the cold-chain integrity essential for this biological medication. You'll receive detailed injection instructions, dose escalation guidance, and ongoing support throughout your treatment journey. Our pharmacy team coordinates dose progressions automatically, sending reminders when it's time to escalate to your next Wegovy dose level.
Wegovy Doses Storage and Practical Considerations
Proper storage of Wegovy doses is crucial for maintaining medication potency and safety throughout your treatment. Unused pens must be stored in your refrigerator at 2-8°C until first use, after which they can remain at room temperature below 30°C for up to 6 weeks. This extended room temperature stability gives Wegovy a significant practical advantage over Mounjaro, which only maintains potency for 21 days outside refrigeration. Each FlexTouch pen contains 4 doses of the same strength, meaning your 0.25mg pen provides 4 weeks of treatment, perfectly aligned with the dose escalation schedule. The pre-filled pen design eliminates measuring errors, while the fine needle (32G) minimises injection discomfort compared to traditional syringes.
Wegovy Doses vs Mounjaro: Making the Right Choice
Selecting between Wegovy doses and Mounjaro requires careful consideration of multiple factors beyond just weight loss efficacy. Wegovy's 5-dose escalation may suit patients who prefer a structured, well-established protocol with extensive long-term safety data from the STEP trials. The once-weekly injection schedule and superior storage flexibility make it practical for busy lifestyles or frequent travellers.
Mounjaro's dual GLP-1/GIP mechanism appeals to patients seeking the newest therapeutic approach, though its 6-dose range and more stringent storage requirements may present practical challenges. Your prescriber will evaluate your medical history, current medications, lifestyle factors, and treatment goals to recommend the most appropriate option, as both represent significant advances in weight management medicine.
Comprehensive Support for Wegovy Doses Journey
EverydayMeds provides ongoing clinical support throughout your Wegovy doses progression, recognising that successful weight management extends beyond medication supply. Our clinical team monitors your escalation schedule, provides injection technique guidance, and offers advice on managing potential side effects during dose transitions. We coordinate with your GP when necessary and provide detailed treatment records for continuity of care. Both Wegovy and Mounjaro are available through our integrated service, allowing your prescriber flexibility to switch treatments if clinical circumstances change. Apply codes FIRST40 or DOSE25 at checkout to access our competitive pricing, and experience the convenience of having both leading weight management medications available from one trusted source.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
